TRUEiGTECH Launches TruePredict to Power FIFA World Cup Sports Prediction Platforms for iGaming Operators 
Sentire(R) Surgical System Receives EU CE Mark (MDR) and Singapore HSA Approval, Cornerstone Robotics Accelerates Global Strategic Expansion 
Unitree Robotics IPO Review Approaches, Shoucheng Holdings Robot Assets Poised for Valuation Re-rating CORRECTION – Argo Blockchain PLC Announces Pricing of Senior Unsecured Notes
The following amendment has been made to the Pricing of Senior Unsecured Notes announcement released…
Gungnir Drills 6.94% Nickel within 31 Metres Grading 0.93% Nickel Starting 20 Metres Below Surface at Lappvattnet
SURREY, BC / ACCESSWIRE / November 15, 2021 / Gungnir Resources Inc. (TSXV:GUG)(OTC PINK:ASWRF) (“Gungnir”…
Northern Superior Resources Increases Previously Announced Non-brokered Private Placement to C$6.5 Million, New Gold INC. To Maintain 9.99% Ownership Stake
Not for distribution to United States newswire services or dissemination in the Unites States SUDBURY,…
GABY Inc. Announces the Appointment of Founder and CEO Margot Micallef to the University of California, Santa Barbara, Women in Leadership Executive Program Advisory Board
Ms. Micallef joins previous executive appointees from companies such as Amazon, Four Seasons, American Airlines,…
EHT through Its Windular Division Installs Proprietary Wind System in Pakistan
NIAGARA FALLS, ON / ACCESSWIRE / November 15, 2021 / EnerDynamic Hybrid Technologies Corp. (TSXV:EHT)…
Trust Stamp Establishes Metapresence(TM) Subsidiary to Offer its Secure Crypto Key Vault Solution
ATLANTA, GA / ACCESSWIRE / November 15, 2021 / Trust Stamp (OTCQX:IDAI, Euronext Growth: AIID…
Contemporary Technology University isn’t charging tuition until a graduate lands a job
New University to Offer Online Master’s Degrees in Cutting-Edge Technology Fields Contemporary Technology University won’t…
Condor Gold plc Announces its Unaudited Results for the Three and Nine Months Ended 30 September, 2021
SURREY, BC / ACCESSWIRE / November 15, 2021 / Condor Gold (AIM:CNR)(TSX:COG) announces that it…
Biophytis Announces US Centers to Restart Recruitment for the COVA Phase 2-3 Study with Sarconeos (BIO101) in COVID-19
PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / November 15, 2021 / Biophytis SA (NasdaqCM:BPTS,…
Adverty Announced as Winner in Techarenan Challenge 2021
STOCKHOLM, SE / ACCESSWIRE / November 15, 2021 / Adverty AB (STO:ADVT) Adverty AB (publ)…
Markerstudy Group leverages investment in Citrix Cloud Services and IGEL OS to deliver a ‘hybrid’ future of office and home working
UK, Reading. November 15, 2021 – IGEL, provider of the next gen edge OS for…
Mainz Biomed to Exhibit ColoAlert at MEDICA 2021, the World’s Largest Medical Trade Fair
BERKELEY, Calif. and MAINZ, Germany, Nov. 15, 2021 (GLOBE NEWSWIRE) — Mainz Biomed N.V. (NASDAQ:MYNZ)…
Glycotope Presents New Data on Carbohydrate-Dependent Antibodies and Fusion-Proteins at the 2021 Society for Immunotherapy of Cancer (SITC) Meeting
Glycotope Presents New Data on Carbohydrate-Dependent Antibodies and Fusion-Proteins at the 2021 Society for Immunotherapy…
Emergex announces approval to initiate Phase I clinical trial of its next generation COVID-19 vaccine candidate
PRESS RELEASE Emergex announces approval to initiate Phase I clinical trial of its next generation…
OSE Immunotherapeutics Presented the First Positive Preclinical Efficacy Data on CLEC-1, a Novel Myeloid Immune Checkpoint Target For Cancer Immunotherapy
Data presented at the 36th Annual Society for Immunotherapy of Cancer (SITC) Meeting NANTES, France,…
ERYTECH Announces Upcoming Poster Presentation at the 2021 American Society of Hematology Annual Meeting
ERYTECH Announces Upcoming Poster Presentation at the 2021 American Society of Hematology Annual Meeting Cambridge,…
Addex to Present at the H.C. Wainwright 7th Annual Israel Virtual Conference
Geneva, Switzerland, November 15, 2021 – Addex Therapeutics (SIX: ADXN, Nasdaq: ADXN), a clinical-stage pharmaceutical company…
Addex Strategic Partner Successfully Completes Phase 1 in Japan with ADX71149
Setting Up Global Expansion of Phase 2 Clinical Evaluation in Epilepsy Patients Ad Hoc Announcement…
Hyloris Announces Earlier than Expected PDUFA Date for Maxigesic® IV
PDUFA date set on 30 June 2022, ahead of the August to September 2022 timeframe…
OXURION NV – First Patient Dosed in Part B of Phase 2 KALAHARI Study Evaluating Multiple Administrations of THR-149 versus aflibercept for Treatment of Diabetic Macular Edema (DME)
THR-149 is a potent plasma kallikrein inhibitor for the treatment of DME in the roughly…